Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Tevogen Bio Holdings Inc (TVGN)

Tevogen Bio Holdings Inc (TVGN)
0.9800 x 14 0.9900 x 20
Post-market by (Cboe BZX)
0.9796 -0.0404 (-3.96%) 04/17/25 [NASDAQ]
0.9800 x 14 0.9900 x 20
Post-market 0.9800 +0.0004 (+0.04%) 19:58 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.9200
Day High
1.0300
Open 1.0100
Previous Close 1.0200 1.0200
Volume 537,000 537,000
Avg Vol 528,565 528,565
Stochastic %K 35.15% 35.15%
Weighted Alpha -76.57 -76.57
5-Day Change -0.0204 (-2.04%) -0.0204 (-2.04%)
52-Week Range 0.2556 - 3.0900 0.2556 - 3.0900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 180,142
  • Shares Outstanding, K 183,893
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,730 K
  • EBIT $ -54 M
  • EBITDA $ -53 M
  • 60-Month Beta -0.84
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8900 +10.07%
on 04/04/25
Period Open: 1.1600
1.2600 -22.25%
on 03/26/25
-0.1804 (-15.55%)
since 03/17/25
3-Month
0.8900 +10.07%
on 04/04/25
Period Open: 1.2800
1.9200 -48.98%
on 01/27/25
-0.3004 (-23.47%)
since 01/17/25
52-Week
0.2556 +283.26%
on 10/09/24
Period Open: 2.2850
3.0900 -68.30%
on 10/25/24
-1.3054 (-57.13%)
since 04/17/24

Most Recent Stories

More News
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market

/CNW/ -- Equity Insider News Commentary – The potential for artificial intelligence (AI) in healthcare is still unfolding, both for patients and providers. A...

AVAI : 0.3699 (-7.53%)
AMST : 2.10 (+1.22%)
BTAI : 1.7400 (-4.40%)
TVGN : 0.9796 (-3.96%)
PLTR : 93.78 (+1.15%)
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO

TVGNW : 0.0483 (+5.23%)
TVGN : 0.9796 (-3.96%)

Business Summary

Semper Paratus entered in definitive agreement for a business combination with Tevogen Bio Inc.

See More

Key Turning Points

3rd Resistance Point 1.1431
2nd Resistance Point 1.0865
1st Resistance Point 1.0331
Last Price 0.9796
1st Support Level 0.9231
2nd Support Level 0.8665
3rd Support Level 0.8131

See More

52-Week High 3.0900
Fibonacci 61.8% 2.0073
Fibonacci 50% 1.6728
Fibonacci 38.2% 1.3383
Last Price 0.9796
52-Week Low 0.2556

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro